| Rebecca Anne Burgess, T-LMFT | |
|
5401 College Blvd, Suite 212, Leawood, KS 66211-1923 | |
| (785) 550-7632 | |
| Not Available |
| Full Name | Rebecca Anne Burgess |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 5401 College Blvd, Leawood, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922553783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2784 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Anne Burgess, T-LMFT 5401 College Blvd, Suite 212, Leawood, KS 66211-1923 Ph: (785) 550-7632 | Rebecca Anne Burgess, T-LMFT 5401 College Blvd, Suite 212, Leawood, KS 66211-1923 Ph: (785) 550-7632 |
News Archive
Levilimab received state approval through a fast-track mechanism, according to Decree No. 441 of the Government of the Russian Federation of April 4, 2020, since its mechanism of action is associated with the control of the cytokine storm, which is one of the manifestations of coronavirus infection.
The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.
The Center for Global Health Policy's "Science Speaks" blog "continues to look at changes in Washington's global health leadership in the wake of November's election," writing, "While Sen. Dick Durbin [D-Ill.], who played a pivotal role in PEPFAR's creation, leaves the Senate Foreign Relations Committee, two new Democratic members, as announced Wednesday, will join the committee which directs foreign aid."
Stereotaxis, Inc. announced today that it had priced the public offering of 6,500,000 shares of its common at a price to the public of $4.00 per share. Stereotaxis has granted the underwriters of the offering an option to purchase up to an additional 975,000 shares of common stock to cover over-allotments, if any. All of the shares in the offering are being offered by Stereotaxis. Stereotaxis expects the offering to close on October 15, 2009.
N-terminal pro-brain natriuretic peptide remains a valid predictor in patients with pulmonary arterial hypertension who have concomitant renal dysfunction, say researchers.
› Verified 7 days ago
Janet Clevenger, LCMFT, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 11111 Nall Avenue, Suite 219, Leawood, KS 66211 Phone: 913-284-0472 Fax: 913-284-0473 | |
Suzan K Coulter, LCMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 11111 Nall Ave, Suite 112, Leawood, KS 66211 Phone: 913-593-9532 Fax: 913-851-4002 | |
Eleanor Ballinger, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 11111 Nall Ave, Leawood, KS 66211 Phone: 913-295-9800 | |
Elaina Susan Pivovar, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 11111 Nall Ave Ste 102, Leawood, KS 66211 Phone: 913-295-9800 | |
Brenda Tally, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5401 College Blvd, Suite 212, Leawood, KS 66211 Phone: 913-269-8173 | |
Molly Witker, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 10977 Granada Ln, Suite 110, Leawood, KS 66211 Phone: 913-486-6655 |